SCHEMBL15659270

SCHEMBL15659270

C[C](C(=O)c1ccccc1)C(Br)C(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 13/20 0.52
CES1 P23141 12/20 0.52
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
XBP1 P17861 1/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 1/20 0.43
PGR P06401 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
HTR2A P28223 1/20 0.41
HRH1 P35367 1/20 0.41
KCNH2 Q12809 1/20 0.41
MDM2 Q00987 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330589 0.82 L3MBTL1 (0.48) CES2CES1LMNAMAPTATM
SCHEMBL330776 0.81 TDP1 (0.56) CES2CES1LMNASMN1; SMN2MAPT
SCHEMBL6181797 0.77 TDP1 (0.52) CES2CES1LMNASMN1; SMN2MAPT
SCHEMBL12228069 0.74 TDP1 (0.50) CES2CES1LMNAMAPTTDP1
SCHEMBL11689583 0.73 PGR (0.49) CES2CES1LMNASMN1; SMN2MAPT
SCHEMBL15759488 0.73 TDP1 (0.44) CES2CES1LMNAMAPTATM
SCHEMBL187606 0.73 TDP1 (0.52) CES2CES1LMNASMN1; SMN2NPSR1
SCHEMBL19695429 0.73 TDP1 (0.52) CES2CES1LMNASMN1; SMN2NPSR1
Benzil SCHEMBL28010897 0.72 CES2 (0.58) CES2CES1LMNASMN1; SMN2NPSR1
SCHEMBL9157738 0.72 TDP1 (0.56) CES2CES1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014065860-A1 FUNCTIONALIZED 1,2,4,5-TETRAZINE COMPOUNDS FOR USE IN BIOORTHOGONAL COUPLING REACTIONS THE GENERAL HOSPITAL CORPORATION (US) 2014-05-01 WO disclosed